$2.39T
Total marketcap
$76.93B
Total volume
BTC 50.73%     ETH 17.00%
Dominance

MediPharm Labs Corp. MLZ.F Stock

0.05 EUR {{ price }} 16.894974% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
25.83M EUR
LOW - HIGH [24H]
0.05 - 0.05 EUR
VOLUME [24H]
500 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 EUR

MediPharm Labs Corp. Price Chart

MediPharm Labs Corp. MLZ.F Financial and Trading Overview

MediPharm Labs Corp. stock price 0.05 EUR
Previous Close 0.04 EUR
Open 0.04 EUR
Bid 0.04 EUR x 0
Ask 0.05 EUR x 0
Day's Range 0.04 - 0.04 EUR
52 Week Range 0.04 - 0.07 EUR
Volume 3 EUR
Avg. Volume 513 EUR
Market Cap 21.18M EUR
Beta (5Y Monthly) 1.172509
PE Ratio (TTM) N/A
EPS (TTM) -0.03 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

MLZ.F Valuation Measures

Enterprise Value -4250146 EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.91765755
Price/Book (mrq) 0.23578946
Enterprise Value/Revenue -0.184
Enterprise Value/EBITDA 0.204

Trading Information

MediPharm Labs Corp. Stock Price History

Beta (5Y Monthly) 1.172509
52-Week Change -12.60%
S&P500 52-Week Change 20.43%
52 Week High 0.07 EUR
52 Week Low 0.04 EUR
50-Day Moving Average 0.05 EUR
200-Day Moving Average 0.05 EUR

MLZ.F Share Statistics

Avg. Volume (3 month) 513 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 390.1M
Float 359.09M
Short Ratio N/A
% Held by Insiders 5.24%
% Held by Institutions 5.11%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -110.96%
Operating Margin (ttm) -100.64%
Gross Margin -5.46%
EBITDA Margin -90.049%

Management Effectiveness

Return on Assets (ttm) -19.80%
Return on Equity (ttm) -39.46%

Income Statement

Revenue (ttm) 23.08M EUR
Revenue Per Share (ttm) 0.08 EUR
Quarterly Revenue Growth (yoy) 19.80%
Gross Profit (ttm) N/A
EBITDA -20786000 EUR
Net Income Avi to Common (ttm) -25614000 EUR
Diluted EPS (ttm) -0.06
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 20.15M EUR
Total Cash Per Share (mrq) 0.05 EUR
Total Debt (mrq) 218K EUR
Total Debt/Equity (mrq) 0.41 EUR
Current Ratio (mrq) 5.301
Book Value Per Share (mrq) 0.19

Cash Flow Statement

Operating Cash Flow (ttm) -13518000 EUR
Levered Free Cash Flow (ttm) -3918625 EUR

Profile of MediPharm Labs Corp.

Country Germany
State ON
City Barrie
Address 151 John Street
ZIP L4N 2L1
Phone 705-719-7425
Website https://www.medipharmlabs.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 130

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Q&A For MediPharm Labs Corp. Stock

What is a current MLZ.F stock price?

MediPharm Labs Corp. MLZ.F stock price today per share is 0.05 EUR.

How to purchase MediPharm Labs Corp. stock?

You can buy MLZ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for MediPharm Labs Corp.?

The stock symbol or ticker of MediPharm Labs Corp. is MLZ.F.

Which industry does the MediPharm Labs Corp. company belong to?

The MediPharm Labs Corp. industry is Drug Manufacturers-Specialty & Generic.

How many shares does MediPharm Labs Corp. have in circulation?

The max supply of MediPharm Labs Corp. shares is 504.4M.

What is MediPharm Labs Corp. Price to Earnings Ratio (PE Ratio)?

MediPharm Labs Corp. PE Ratio is now.

What was MediPharm Labs Corp. earnings per share over the trailing 12 months (TTM)?

MediPharm Labs Corp. EPS is -0.03 EUR over the trailing 12 months.

Which sector does the MediPharm Labs Corp. company belong to?

The MediPharm Labs Corp. sector is Healthcare.